20/20 Capital Management »

Vaneck Vectors Pharmaceutical etf shares owned by 20/20 Capital Management

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by 20/20 Capital Management from 13F filings

Historical chart of 20/20 Capital Management investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by 20/20 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by 20/20 Capital Management

Quarter filed Position value Share count Share price at filing
2021-06-30 $9.3M 128k 73.06
2021-03-31 $7.8M 112k 69.02
2020-12-31 $6.7M 98k 68.66
2020-09-30 $438k 7.0k 62.14

More positions owned by 20/20 Capital Management

Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Specialized Funds Div App Etf (VIG)
Proshares Tr S&p 500 Dv Arist (NOBL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Blackrock Science & Technolo SHS (BST)
Spdr Ser Tr Portfolio Sh Tsr (SPTS)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
J P Morgan Exchange-traded F Ultra Shrt Inc (JPST)
Microsoft Corporation (MSFT)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vaneck Vectors Etf Tr Pharmaceutical (PPH)
J P Morgan Exchange-traded F Intl Bd Opp Etf (JPIB)
Wisdomtree Tr Emer Mkt High Fd (DEM)
Apple (AAPL)

View all positions for 20/20 Capital Management

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Thrivent Financial for Lutherans
Miller Investment Management
Mivtachim The Workers Social Insurance Fund
Northwestern Mutual Wealth Management Company
Adamsbrown Wealth Consultants
Prime Capital Investment Advisors
Bank of America Corporation
LPL Financial
Phoenix Holdings
J.Safra Asset Management
Citadel Advisors
WT Wealth Management

View all funds holding Vaneck Vectors Pharmaceutical etf